MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology

MindBio Therapeutics announced the development of AI-powered fatigue recognition technology for its Edge AI Intoxication Detection Kiosks, targeting high-risk industries and expanding its voice-based diagnostics platform.

SD Metrowire Staff
Technology
MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, intended to be added as a commercial feature to the company's Edge AI Intoxication Detection Kiosks. The announcement highlights the company's continued expansion of its voice-based diagnostics platform, which initially focused on detecting intoxication and neurological impairment.

According to the press release, the fatigue detection module is designed for high-risk industries including aviation, road transport, and mining. By analyzing voice patterns, the technology aims to identify signs of fatigue, which is a critical safety concern in these sectors. The company expects initial commercial testing of the kiosk platform to begin in late second quarter 2026.

MindBio's AI prediction model uses over 50 million data points to predict alcohol intoxication with high accuracy, solely through voice analysis. The company is developing an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for detecting drug and alcohol intoxication. The kiosks are intended for use in environments such as mining, aviation, construction, and law enforcement.

The addition of fatigue detection technology represents a significant expansion of MindBio's capabilities. Fatigue is a major contributor to accidents in high-risk industries, and the ability to detect it through non-invasive voice analysis could enhance workplace safety. The technology complements the existing intoxication detection features, offering a more comprehensive safety solution.

MindBio Therapeutics is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The company's AI model leverages a vast dataset to achieve remarkable accuracy. The enterprise platform under development aims to provide real-time monitoring and alerts for impairment, potentially reducing accidents and improving operational safety.

This development comes as industries increasingly seek automated, non-invasive methods to monitor worker fitness for duty. The integration of fatigue detection into the same platform as intoxication detection could streamline safety protocols and provide a unified solution for employers.

The press release also noted that the latest news and updates regarding MBQIF are available in the company's newsroom at https://nnw.fm/MBQIF. For more details on the announcement, the full press release can be accessed at https://nnw.fm/WWgcb.

Blockchain Registration

QR Code for Blockchain Registration